[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
Webmail::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 35, Issue 1 (spring 2025) ::
MEDICAL SCIENCES 2025, 35(1): 1-13 Back to browse issues page
A review of the use of cyanobacterial metabolites in the treatment of viral and cancer diseases
Bahareh Nowruzi1 , Fatemeh Bagheri2
1- Associate Professor, Department of Biotechnology, Faculty of Converging Sciences and Technologies, Islamic Azad University, Science and Research Branch, Tehran, Iran , bahare77biol@gmail.com
2- Department of Microbiology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
Abstract:   (952 Views)

Many medical and non-medical research laboratories around the world are constantly trying to produce an effective vaccine or antiviral medicine. Current medical knowledge of the world has made significant progress in line with the corona virus and cancer treatment. Meanwhile, many natural compounds found in cyanobacteria have attracted the attention of many physicians due to their durability and high reliability. Cyanobacteria are rich in bioactive compounds that exhibit diverse biological activities including anti-proliferative, cytotoxic and anti-neoplastic properties. Many of these compounds are currently being studied in clinical trials. In this review article, newly discovered bioactive compounds from different cyanobacteria species that have strong antiviral activity against respiratory infections and also compounds such as apratoxin, simplostatin 1, bartolosides, chylobolid, bisbromoamides, carmaphysins and anamides that have anticancer activity on numerous cancer cell lines are introduced. The studies show that currently, there are no clear guidelines on the approval of bioactive compounds derived from cyanobacteria for the treatment of diseases. Although the use of these compounds is not usually accompanied by side effects, more research should be focused on these compounds to increase their safety and effectiveness. In this review article, by studying the latest available articles, the effectiveness of natural compounds in cyanobacteria in the treatment of viral and cancer diseases is discussed.

Keywords: Antiviral drugs, Corona virus, Cyanobacteria, Anticancer compounds
Full-Text [PDF 971 kb]   (214 Downloads)    
Semi-pilot: Review | Subject: Biology
Received: 2024/06/23 | Accepted: 2024/08/14 | Published: 2025/03/30
References
1. Hussein HA, Khaphi FL, Saeed ZK. Cytotoxicity of bioactive compounds derived from cyanobacteria. INNOSC Theranostics and Pharmacological Sciences 2024; 7: 1388. [DOI:10.36922/itps.1388]
2. Nowruzi B, Hashemizaveh N. A Review of New Anticancer Nanoformulations based on Cyanobacteria and Microalgae and its Application in Medical Sciences, Dentistry and Pharmacy. SSU_Journals 2024; 31:7070-89. [In Persian] [DOI:10.18502/ssu.v31i10.14560]
3. Prabhu S, Vijayakumar S, Praseetha P. Cyanobacterial metabolites as novel drug candidates in corona viral therapies: A review. Chronic Dis Transl Med 2022;8:172-83. [DOI:10.1002/cdt3.11]
4. Jafari Porzani S, Konur O, Nowruzi B. Cyanobacterial natural products as sources for antiviral drug discovery against COVID-19. J Biomol Struct Dyn 2022;40:7629-44. [DOI:10.1080/07391102.2021.1899050]
5. Anvar SAA, Nowruzi B. A review of microalgae as dietary and medicinal useful complements. Journal of Food Technology and Nutrition 2022; 2: 55-74. [In Persian]
6. Nowruzi B, Adelkhani M, Anvar A. A review of the cytotoxic, antioxidant and antimicrobial activity of nanoparticles biosynthesized from cyanobacteria. Journal of Comparative Pathobiology 2023; 20: 4039-52. [In Persian]
7. Nowruzi B, Beiranvand H. A review of medical applications of cyanobacteria. Journal of Isfahan Medical School 2024; 42: 69-83.
8. Eghtedari M, Jafari Porzani S, Nowruzi B. Anticancer potential of natural peptides from terrestrial and marine environments: A review. Phytochem Lett 2021;42:87-103. [DOI:10.1016/j.phytol.2021.02.008]
9. Nowruzi B, Sarvari G, Blanco S. Applications of cyanobacteria in biomedicine. In: Konur O, Ed. Handbook of algal science, technology and medicine. Cambridge, Massachusetts, United States: Academic Press; 2020. p.441-53. [DOI:10.1016/B978-0-12-818305-2.00028-0]
10. Baig MS, Rajpoot S, Ohishi T, Savai R, Seidel S, Kamennaya NA, et al. Anti-lung cancer properties of cyanobacterial bioactive compounds. Arch Microbiol 2022;204:603. [DOI:10.1007/s00203-022-03194-0]
11. Nowruzi B, Hashemi N. A Review on the Antimicrobial Effects of Nanoparticles and Atmospheric Cold Plasma Technology. Journal of Isfahan Medical School 2023; 41: 631-42. [In Persian]
12. Baig MS, Rajpoot S, Ohishi T, Savai R, Seidel S, Kamennaya NA, et al. Anti-lung cancer properties of cyanobacterial bioactive compounds. Arch Microbiol 2022;204:603. [DOI:10.1007/s00203-022-03194-0]
13. Wijewickrama M, Greene A, Cock I. Therapeutics from Cyanobacteria: A Review of Cyanobacteria-Derived Compounds as Anti-cancer Drug Leads. Pharmacognosy Reviews 2023; 17: 230-246. [DOI:10.5530/phrev.2023.17.3]
14. Nawaz T, Gu L, Fahad S, Saud S, Jiang Z, Hassan S, et al., A comprehensive review of the therapeutic potential of cyanobacterial marine bioactives: Unveiling the hidden treasures of the sea. Food and Energy Security 2023; 12: p. e495. [DOI:10.1002/fes3.495]
15. Mandal S, Rath J. Anticancer drug development from cyanobacteria. In: Mandal S, Rath J, Eds. Extremophilic cyanobacteria for novel drug development. Berlin, Germany: Springer; 2015. p.63-78. [DOI:10.1007/978-3-319-12009-6_4]
16. Tiwari AK, Tiwari BS. Cyanotherapeutics: An emerging field for future drug discovery. Applied phycology 2020; 1: 44-57. [DOI:10.1080/26388081.2020.1744480]
17. Golizadeh Z, Nowruzi B, FalsafiS. A Study of Antimicrobial Activity of Biosynthesized Nanoparticles via Two Different Methods by Freshwater Cyanobacteria Nostoc sp. Biological Journal of Microorganism 2023;12: 51-68. [In Persian]
18. Saad MH, El-Fakharany EM, Salem MS, Sidkey NM. The use of cyanobacterial metabolites as natural medical and biotechnological tools: review article. J Biomol Struct Dyn 2022;40:2828-50. [DOI:10.1080/07391102.2020.1838948]
19. Nowruzi B, Khoshnood N, Sory S, Gharooni Fard S, Rezaei MR, Ayoub Nejad F. Microbial Secondary Metabolites to Control Disease: A Mini-Review. Biotechnological Journal of Environmental Microbiology 2022; 1: 165-176.
20. Sami N, Ahmad R, Fatma T. Exploring algae and cyanobacteria as a promising natural source of antiviral drug against SARS-CoV-2. Biomed J 2021;44:54-62. [DOI:10.1016/j.bj.2020.11.014]
21. Khalifa SAM, Shedid ES, Saied EM, Jassbi AR, Jamebozorgi FH, Rateb ME, et al. Cyanobacteria-From the Oceans to the Potential Biotechnological and Biomedical Applications. Mar Drugs 2021;19:241. [DOI:10.3390/md19050241]
22. Sangtani R, Ghosh A, Jha HC, Parmar HS, Bala K. Potential of algal metabolites for the development of broad-spectrum antiviral therapeutics: Possible implications in COVID-19 therapy. Phytother Res 2021;35:2296-316. [DOI:10.1002/ptr.6948]
23. Shawon J, Akter Z, Hossen MM, Akter Y, Sayeed A, Junaid M, et al. Current Landscape of Natural Products against Coronaviruses: Perspectives in COVID-19 Treatment and Anti-viral Mechanism. Curr Pharm Des 2020;26:5241-60. [DOI:10.2174/1381612826666201106093912]
24. Anvar SAA, Nowruzi B, Afshari G. A review of the application of nanoparticles biosynthesized by microalgae and cyanobacteria in medical and veterinary sciences. Iranian Journal of Veterinary Medicine 2023;17:1-18. [DOI:10.32598/IJVM.17.1.1005309]
25. Vougogiannopoulou K, Corona A, Tramontano E, Alexis MN, Skaltsounis AL. Natural and Nature-Derived Products Targeting Human Coronaviruses. Molecules 2021;26:448. [DOI:10.3390/molecules26020448]
26. Frediansyah A, Sofyantoro F, Alhumaid S, Al Mutair A, Albayat H, Altaweil HI, et al. Microbial Natural Products with Antiviral Activities, Including Anti-SARS-CoV-2: A Review. Molecules 2022;27:4305. [DOI:10.3390/molecules27134305]
27. Pradhan B, Nayak R, Patra S, Bhuyan PP, Dash SR, Ki JS, et al. Cyanobacteria and Algae-Derived Bioactive Metabolites as Antiviral Agents: Evidence, Mode of Action, and Scope for Further Expansion; A Comprehensive Review in Light of the SARS-CoV-2 Outbreak. Antioxidants (Basel) 2022;11:354. [DOI:10.3390/antiox11020354]
28. Singh U, Gandhi HA, Nikita, Bhattacharya J, Tandon R, Tiwari GL, et al. Cyanometabolites: molecules with immense antiviral potential. Arch Microbiol 2023;205:164. [DOI:10.1007/s00203-023-03514-y]
29. Mazur-Marzec H, Cegłowska M, Konkel R, Pyrć K. Antiviral Cyanometabolites-A Review. Biomolecules 2021;11:474. [DOI:10.3390/biom11030474]
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nowruzi B, Bagheri F. A review of the use of cyanobacterial metabolites in the treatment of viral and cancer diseases. MEDICAL SCIENCES 2025; 35 (1) :1-13
URL: http://tmuj.iautmu.ac.ir/article-1-2273-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 35, Issue 1 (spring 2025) Back to browse issues page
فصلنامه علوم پزشکی دانشگاه آزاد اسلامی واحد پزشکی تهران Medical Science Journal of Islamic Azad Univesity - Tehran Medical Branch
Persian site map - English site map - Created in 0.04 seconds with 37 queries by YEKTAWEB 4710